SCRIPINTELLIGENCE.COM | ABOUT | SUBSCRIBE | CONTACT US

THE SCRIP 100 RANKING 2011 Ranking (2010 in brackets; NR = not ranked) Company 2011 pharma sales ($m) 2010 pharma sales ($m) 1 (1) Pfizer 57,747 58,523 2 (2) Sanofi 46,454 40,310 3 (4) Novartis 41,981 38,898 4 (3) Merck & Co 41,289 39,811 5 (6) Roche 36,991 35,568 6 (5) GlaxoSmithKline 35,591 36,132 7 (7) AstraZeneca 33,591 33,269 8 (8) Johnson & Johnson 24,368 22,396 View the interactive table

Download the pdf now

Take a free trial today SCRIP Intelligence is the single source for all pharmaceutical business intelligence. Strengthen your strategic and commercial knowledge with full news, data and analysis. Sign up for a free trial at SCRIPintelligence.com Click here to read latest headlines from SCRIP intelligence

C-SUITE

• The sense and sensibility of Shire
• How Pfizer reinvented invention
• Sharing the strategy with AZ

More C-Suite

BUSINESS

• Orphan disease specialists find a home
• A smaller piece of the pie: biosimilar deals
• Patent expiry calendar 2013

More Business

POLICY

• In conversation: Guido Rasi
• Obamacare: Let the wild rumpus begin
• Biosimilars: boom or bust?

More Policy

R&D

• US approvals in 2013
• The door is open for innovation
• NCE approvals 2011-2012

More R&D

EMERGING MARKETS

• Natco's CEO, India's price warrior
• New money for old China?
• Revolution may spring pharma opportunity in MENA

More Emerging Markets

MARKET ACCESS

• Teva takes it step by step in Brazil
• Evidence, more evidence!
• Famine or feast as Japan debates pricing reforms?

More Market Acess

HOME	SCRIP 100	BUSINESS	LEADERSHIP	R&D	THE PATIENT
EMERGING MARKETS	POLICY	MARKET ACCESSS	MANUFACTURING	FUTUROLOGY	SCRIP ASIA 100
Informa plc. All rights reserved. This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36